Trade Summary

2 days ago, SCHIMMEL PAUL, serving as Dir at aTYR PHARMA INC (ATYR), purchased 100,000 shares at $0.50 per share, for a total transaction value of $49,630.00. Following this transaction, SCHIMMEL PAUL now holds 779,143 shares of ATYR.

This purchase represents a 14.72% increase in SCHIMMEL PAUL's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, May 27, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, May 28, 2026 at 4:12 PM ET, 1 day after the trade was made.

aTYR PHARMA INC operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.